Bevacizumab-induced transient remodeling of the vasculature in neuroblastoma xenografts results in improved delivery and efficacy of systemically administered chemotherapy.

Source:http://linkedlifedata.com/resource/pubmed/id/17606728

Clin. Cancer Res. 2007 Jul 1 13 13 3942-50

Download in:

View as

General Info

PMID
17606728